12:00 AM
Nov 19, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Abstral fentanyl regulatory update

Kyowa submitted an NDA to Japan's Ministry of Health, Labor and Welfare (MHLW) for Abstral fentanyl to treat breakthrough cancer pain. The application includes additional clinical data requested by...

Read the full 124 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >